Steven R. Cummings, MD
Steven R. Cummings, MD
SF Coordinating Center, CPMC Research Institute and UC San Francisco
Verified email at
Cited by
Cited by
Designing clinical research
WS Browner, TB Newman, SR Cummings, DG Grady
Lippincott Williams & Wilkins, 2022
Epidemiology and outcomes of osteoporotic fractures
SR Cummings, LJ Melton
The Lancet 359 (9319), 1761-1767, 2002
Risk factors for hip fracture in white women
SR Cummings, MC Nevitt, WS Browner, K Stone, KM Fox, KE Ensrud, ...
New England journal of medicine 332 (12), 767-773, 1995
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
DM Black, SR Cummings, DB Karpf, JA Cauley, DE Thompson, MC Nevitt, ...
The Lancet 348 (9041), 1535-1541, 1996
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial
B Ettinger, DM Black, BH Mitlak, RK Knickerbocker, T Nickelsen, ...
Jama 282 (7), 637-645, 1999
Denosumab for prevention of fractures in postmenopausal women with osteoporosis
SR Cummings, JS Martin, MR McClung, ES Siris, R Eastell, IR Reid, ...
New England Journal of Medicine 361 (8), 756-765, 2009
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
DM Black, PD Delmas, R Eastell, IR Reid, S Boonen, JA Cauley, ...
New England Journal of Medicine 356 (18), 1809-1822, 2007
Hormone therapy to prevent disease and prolong life in postmenopausal women
D Grady, SM Rubin, DB Petitti, CS Fox, D Black, B Ettinger, VL Ernster, ...
Annals of internal medicine 117 (12), 1016-1037, 1992
Bone density at various sites for prediction of hip fractures
SR Cummings, W Browner, DM Black, MC Nevitt, HK Genant, J Cauley, ...
The Lancet 341 (8837), 72-75, 1993
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial
SR Cummings, DM Black, DE Thompson, WB Applegate, ...
Jama 280 (24), 2077-2082, 1998
Risk factors for recurrent nonsyncopal falls: a prospective study
MC Nevitt, SR Cummings, S Kidd, D Black
Jama 261 (18), 2663-2668, 1989
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial
SR Cummings, S Eckert, KA Krueger, D Grady, TJ Powles, JA Cauley, ...
Jama 281 (23), 2189-2197, 1999
Epidemiology of osteoporosis and osteoporotic fractures
SR Cummings, JL Kelsey, MC Nevitt, KJ O'DOWD
Epidemiologic reviews 7 (1), 178-208, 1985
Calcium plus vitamin D supplementation and the risk of fractures
RD Jackson, AZ LaCroix, M Gass, RB Wallace, J Robbins, CE Lewis, ...
New England Journal of Medicine 354 (7), 669-683, 2006
Delineando a pesquisa clínica-4
SB Hulley, SR Cummings, WS Browner, DG Grady, TB Newman
Artmed Editora, 2015
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial
DM Black, AV Schwartz, KE Ensrud, JA Cauley, S Levis, SA Quandt, ...
Jama 296 (24), 2927-2938, 2006
Vertebral fractures and mortality in older women: a prospective study
DM Kado, WS Browner, L Palermo, MC Nevitt, HK Genant, SR Cummings, ...
Archives of internal medicine 159 (11), 1215-1220, 1999
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ...
Osteoporosis international 18, 1033-1046, 2007
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial
JA Cauley, J Robbins, Z Chen, SR Cummings, RD Jackson, AZ LaCroix, ...
Jama 290 (13), 1729-1738, 2003
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial
DM Black, DE Thompson, DC Bauer, K Ensrud, T Musliner, MC Hochberg, ...
The Journal of Clinical Endocrinology & Metabolism 85 (11), 4118-4124, 2000
The system can't perform the operation now. Try again later.
Articles 1–20